Dr. Peter Chen, MD

Dr. Chen practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Chen's NPI, 1225100183, was assigned on November 15, 2006. Dr. Chen graduated from Baylor College Of Medicine in 1999. Dr. Chen holds California license C127689.

Dr. Chen's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Chen's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chen practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Chen's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Chen is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Chen's licenses on file in 3 states: California, Washington and Texas.

Dmand AI lists asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD) and chronic respiratory failure among the conditions Dr. Chen treats.

CMS data shows 181 Medicare services from Dr. Chen across 3 procedure codes in 2024, for 109 Medicare patients. Medicare paid $28,013 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 109 Medicare patients who saw Dr. Chen in 2024. The largest group is 65 to 74, with 40 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 50% are also on Medicaid. Their average risk score is 4.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chen's median patient age at 70, with 51% women.

In 2024, Dr. Chen wrote 108 Medicare Part D claims for 17 patients. 61% of them were for generic drugs. CMS names the drug for 38 of them, across 3 drugs with 11 or more claims each, at $23,305 in total drug cost. In 2023, CMS named 59 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Chen for performance year 2024, reported as part of a group. Dr. Chen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chen as offering telehealth.

Dmand AI links 35 papers to Dr. Chen, published from 2007 to 2025. 2023 was the busiest year, with 5. The most frequent topics are Lung, SARS-CoV-2 and COVID-19. Dr. Chen has published most often in Am J Respir Cell Mol Biol. Dr. Chen's most frequent co-authors are Tanyalak P. Parimon, MD, Peter Chang Chen, MD and Paul Wesley Noble, MD.

CMS Open Payments shows 26 general payments to Dr. Chen from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 74% of the total. Gilead Sciences, Inc. paid the most, $9,201.

Dr. Chen graduated from Baylor College Of Medicine in 1999. Dr. Chen is a member of AHA and ATS.

Dr. Chen is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.